Ratings by Brookline Capital Markets (Kemp Dolliver)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2026 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2026 | Lisata Therapeutics, Inc | LSTA | Downgrade | Hold (Buy) |
2.16 (3.40) |
57.41% | Details | |
| 1/21/2026 | Rein Therapeutics | RNTX | Downgrade | Hold (Buy) |
1.20 (1.04) |
-13.33% | Details | |
| 12/18/2025 | Verrica Pharmaceuticals | VRCA | Upgrade | Buy (Hold) |
8.60 (6.12) |
-28.84% | Details | |
| 11/3/2025 | Rein Therapeutics | RNTX | Upgrade | Buy (Hold) |
1.57 (1.04) |
-33.76% | Details | |
| 9/29/2025 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2025 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2025 | iBio, Inc. | IBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2025 | iBio, Inc. | IBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2025 | Rein Therapeutics | RNTX | Downgrade | Hold (Buy) |
1.19 (1.57) |
31.93% | Details | |
| 8/18/2025 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | IceCure Medical Ltd. | ICCM | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2025 | Radiopharm Theranostics | RADX | New Coverage | Buy (N/A) |
4.43 (4.19) |
-5.42% | Details | |
| 7/15/2025 | Lisata Therapeutics, Inc | LSTA | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2025 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Perspective Therapeutics Inc | CATX | New Coverage | Buy (N/A) |
2.61 (3.41) |
30.65% | Details | |
| 3/4/2025 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2024 | Y-mAbs Therapeutics | YMAB | New Coverage | Buy (N/A) |
10.38 (8.61) |
-17.05% | Details | |
| 11/15/2024 | Eyenovia | EYEN | Downgrade | Hold (Buy) |
0.34 (15.82) |
4552.94% | Details | |
| 10/2/2024 | Verrica Pharmaceuticals | VRCA | Downgrade | Hold (Buy) |
1.37 (8.60) |
527.74% | Details | |
| 9/12/2024 | Oncternal Therapeutics | ONCT | Downgrade | Hold (Buy) |
4.16 (0.53) |
-87.26% | Details | |
| 7/22/2024 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
2.15 (1.75) |
-18.6% | Details | |
| 5/15/2024 | Dare Bioscience | DARE | Upgrade | Buy (Hold) |
0.32 (2.11) |
559.38% | Details | |
| 4/17/2024 | Dare Bioscience | DARE | Downgrade | Hold (Buy) |
0.48 (2.11) |
339.58% | Details | |
| 3/19/2024 | Fusion Pharmaceuticals | FUSN | Downgrade | Hold (Buy) |
10.64 (21.55) |
102.54% | Details | |
| 1/25/2024 | Outlook Therapeutics Incs. | OTLK | Upgrade | Buy (Hold) |
0.44 (1.59) |
261.36% | Details | |
| 12/21/2023 | POINT Biopharma Global Inc. | PNT | Downgrade | Hold (Buy) |
12.45 (12.50) |
0.4% | Details | |
| 12/4/2023 | Oncternal Therapeutics | ONCT | Upgrade | Buy (Hold) |
0.34 (0.53) |
55.88% | Details | |
| 11/30/2023 | Lantheus Holdings | LNTH | New Coverage | Buy (N/A) |
68.99 (110.94) |
60.81% | Details | |
| 10/17/2023 | Eyenovia | EYEN | New Coverage | Buy (N/A) |
1.38 (0.34) |
-75.36% | Details | |
| 9/6/2023 | Procaps Group S.A. | PROC | Downgrade | Hold (Buy) |
3.96 (1.01) |
-74.49% | Details | |
| 9/5/2023 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | POINT Biopharma Global Inc. | PNT | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Atreca Inc. | BCEL | Downgrade | Hold (Buy) |
0.88 (0.09) |
-89.77% | Details | |
| 7/11/2023 | electroCore Inc. | ECOR | New Coverage | Buy (N/A) |
4.86 (8.64) |
77.78% | Details | |
| 6/5/2023 | Bellerophon Therapeutics | BLPH | Downgrade | Hold (Buy) |
7.06 (0.01) |
-99.86% | Details | |
| 5/26/2023 | 9 Meter Biopharma | NMTR | Downgrade | Hold (Buy) |
0.78 (0.07) |
-91.03% | Details | |
| 4/4/2023 | Oncternal Therapeutics | ONCT | Downgrade | Hold (Buy) |
0.79 (0.53) |
-32.91% | Details | |
| 3/16/2023 | Fusion Pharmaceuticals | FUSN | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2023 | Apexigen Inc | APGN | Downgrade | Hold (Buy) |
0.84 (0.39) |
-53.57% | Details | |
| 2/21/2023 | Oncternal Therapeutics | ONCT | New Coverage | Buy (N/A) |
1.03 (0.53) |
-48.54% | Details | |
| 2/15/2023 | electroCore Inc. | ECOR | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2023 | Dare Bioscience | DARE | New Coverage | Buy (N/A) |
1.15 (2.11) |
83.48% | Details | |
| 2/14/2023 | Fusion Pharmaceuticals | FUSN | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | Procaps Group S.A. | PROC | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2023 | Atreca Inc. | BCEL | New Coverage | Buy (N/A) |
1.47 (0.09) |
-93.88% | Details | |
| 1/13/2023 | electroCore Inc. | ECOR | New Coverage | Buy (N/A) |
0.28 (8.64) |
2985.71% | Details | |
| 12/30/2022 | IceCure Medical Ltd. | ICCM | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Apexigen Inc | APGN | New Coverage | Buy (N/A) |
1.07 (0.39) |
-63.55% | Details | |
| 11/21/2022 | POINT Biopharma Global Inc. | PNT | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2022 | Bioceres Crop Solutions | BIOX | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Novan | NOVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2022 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Procaps Group S.A. | PROC | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2022 | Bellerophon Therapeutics | BLPH | Maintain | (N/A) |
|
Details | ||
| 3/9/2022 | Verrica Pharmaceuticals | VRCA | New Coverage | Buy (N/A) |
7.70 (6.12) |
-20.52% | Details | |
| 2/2/2022 | IceCure Medical Ltd. | ICCM | New Coverage | Buy (N/A) |
2.34 (4.86) |
107.69% | Details | |
| 12/14/2021 | Procaps Group S.A. | PROC | New Coverage | Buy (N/A) |
10.00 (1.01) |
-89.9% | Details | |
| 12/1/2021 | POINT Biopharma Global Inc. | PNT | New Coverage | Buy (N/A) |
8.21 (12.50) |
52.25% | Details | |
| 11/10/2021 | Bioceres Crop Solutions | BIOX | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2021 | Novan | NOVN | New Coverage | Buy (N/A) |
7.42 (0.09) |
-98.79% | Details | |
| 7/6/2021 | Bioceres Crop Solutions | BIOX | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2021 | Bellerophon Therapeutics | BLPH | New Coverage | Buy (N/A) |
4.08 (0.01) |
-99.75% | Details |
